X-linked adrenoleukodystrophy is a rare genetic condition that causes problems with the white matter in your nervous system and adrenal glands. X-linked adrenoleukodystrophy (X-ALD) is a genetic ...
Viking Therapeutics, Inc. VKTX recently received a setback as the FDA placed a clinical hold on its early-stage study of pipeline candidate VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD ...
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic ...
X-linked adrenoleukodystrophy (X-ALD) is a debilitating disease caused by mutations in the ABCD1 gene. Approximately 30% of affected boys develop the progressive ...
(RTTNews) - Viking Therapeutics, Inc. (VKTX), Wednesday announced positive data from Phase 1b study of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD). X-ALD is a rare and often fatal ...
Cerebral X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder characterized by accumulation of very long chain fatty acids, which ultimately leads to demyelination. The mechanisms that trigger ...
NeuroVia Closes Series A Financing Round of $14M to Develop Novel Treatment Option for X-ALD Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare genetic neurological diseases, announced the closing of a Series A ...
THE GROUND BY SUNDAY AFTERNOON. ALL RIGHT. THANK YOU OLGA. ALDI IS A RARE GENETIC DISEASE THAT AFFECTS 1 IN 17,000 PEOPLE WORLDWIDE. THE DIAGNOSIS HIT ONE FAMILY WHO IS ORIGINALLY FROM ALBUQUERQUE.
Viking Therapeutics Inc.’s stock rose 1.4% in premarket trade Wednesday, after the biotech reported positive data from an early-stage trial of a treatment for the rare, and often fatal, metabolic ...
Sanofi Genzyme and Novartis’ venture arms have backed NeuroVia, an upstart that wants to help treat the rare CNS disorder X-linked adrenoleukodystrophy. The $14 million series A, which was also backed ...
UPDATE: FoxNews.com first covered Carter Brischler's medical battle in 2016, eight months after he was diagnosed with adrenoleukodystrophy (ALD). His family shared the tragic news of his Feb. 6, 2017 ...
X-linked adrenoleukodystrophy (X-ALD) is caused by a defect in the gene ABCD1, which maps to Xq28 and codes for a peroxisomal membrane protein that is a member of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results